LYY5:F:F-Mullti Units France - Lyxor MSCI Europe (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 203.9

Change

-2.05 (-1.00)%

Market Cap

N/A

Volume

344.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.74 (-1.42%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-13.56 (-2.41%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.79 (-1.38%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.23 (-1.47%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.60 (-1.55%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

-1.29 (-1.30%)

USD 51.63B
0ZC:F Zscaler Inc

-3.30 (-1.48%)

USD 37.92B
BSND:F Danone SA

+0.20 (+1.39%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-1.66 (-1.29%)

USD 24.77B

ETFs Containing LYY5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.82% 81% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.82% 81% B- 72% C
Trailing 12 Months  
Capital Gain 8.64% 74% C 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.64% 72% C 59% D-
Trailing 5 Years  
Capital Gain 81.79% 74% C 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 81.79% 74% C 53% F
Average Annual (5 Year Horizon)  
Capital Gain 11.01% 75% C 68% D+
Dividend Return 11.01% 72% C 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.76% 62% D 90% A-
Risk Adjusted Return 102.32% 92% A 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike